|
| Thursday, December 12, 2019 |
|
|
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals |
| Holista CollTech (ASX: HCT, Holista) today announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system. This patented process can apply to a whole range of molecules including the Cannabidiol (CBD) oil industry. more info >> |
|
| Friday, November 8, 2019 |
|
|
iGalen and Holista announce resolution with ATM Metabolics |
| iGalen and Holista are pleased to announce they have resolved the disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin. more info >> |
|
| Friday, October 18, 2019 |
|
|
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea |
| Holista CollTech Ltd (Holista) and SunFresh Fruit Hub Sdn Bhd (Fruit Hub) have announced a research and development collaboration to produce three key healthy ingredients for the global Bubble Tea industry, a popular global drink fad that has raised serious concerns about its effect on diabetes and obesity. more info >> |
|
| Thursday, October 17, 2019 |
|
|
Holista Collaborates to Develop World's First Combined Suite of Healthybubble Tea Ingredients amidst Concerns of Diabetes and Obesity |
| Holista CollTech Ltd (ASX:HCT, "Holista") and SunFresh Fruit Hub Sdn Bhd ("Fruit Hub") announced today a research and development collaboration to produce three key healthy ingredients for the global Bubble Tea industry, a popular global drink fad that has raised serious concerns about its effect on diabetes and obesity. more info >> |
|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, January 16, 2019 |
|
|
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai |
| Food ingredient specialist Holista CollTech Ltd (ASX:HCT, "Holista") has partnered Bursa Malaysia-listed Kawan Food Berhad ("Kawan Food") to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets. more info >> |
|
| Wednesday, February 14, 2018 |
|
|
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada |
| Holista CollTech Ltd ("Holista") (ASX: HCT) is pleased to announce group company Holista Food's Inc. ("HolistaFoods") has signed a 3-year MoU to supply its patented low glycemic index ("GI") mix to Wing's Group - North America's leading noodle supplier. more info >> |
|
| Tuesday, October 24, 2017 |
|
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
| SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, October 19, 2017 |
|
|
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38 |
| Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity. more info >> |
|
|
|
